卵巢肿瘤 | Medical guideline

首页 肿瘤学指南  卵巢肿瘤

卵巢肿瘤

按发表年份

Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice – Biopathology of Ovarian Borderline Tumors

 2020年发布于 Gynecologie Obstetrique Fertilite et Senologie 48卷第9期 所属人体系统：生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

Anatomopathologie Borderline Tumor Extemporané Frozen Section Mucineuse Mucinous Ovaire Pathology Reproductibilité Serous Tumeur Frontière Séreuse.
指南简介 原文链接
Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages

 2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

Adnexectomy Annexectomie Appendectomy Appendicectomie Biopsies Péritonéales Borderline Ovarian Tumour Borderline Tumour Chirurgie De Restadification Hysterectomy Hystérectomie Kystectomie Ovarienne Lymphadenectomy Lymphadénectomie Omentectomie Omentectomy Ovarian Cystectomy Ovarian Tumour Peritoneal Biopsies Peritoneal Staging Restaging Surgery Stadification Péritonéale Tumeur Borderline Tumeur De L’ovaire Tumeur Frontière De L’ovaire.
指南简介 原文链接
Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text

 2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

Borderline Ovarian Tumour Practice Guidelines Recommandations Pour La Pratique Clinique Tumeur Frontière De L’ovaire.
指南简介 原文链接
O-RADS US Risk Stratification and Management System: a Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee

 2020年发布于 Radiology 294卷第1期 所属人体系统：生殖 | 卵巢肿瘤

 American College of Radiology Ovarian-Adnexal Reporting and Data System Committee

Ovarian Adnexal Consensus
指南简介 原文链接
Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging

 2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

Borderline Frontière IRM MRI Ovaire Ovary Papillary Projection Ultrasonography Végétation Échographie.
指南简介 原文链接
Berlin, 4th May 2020 S3 Guideline for Ovarian Cancer Updated: New Recommendations on Surgical Interventions, PARP Inhibitors and Radiation Therapy (AWMF Registration Number 032-035OL, Diagnostics, Therapy and Aftercare of Malignant Ovarian Tumors)

 2020年发布于 Geburtshilfe Und Frauenheilkunde 80卷第8期 所属人体系统：生殖 | 卵巢肿瘤

 无

Ovarian Cancer Surgical Interventions PARP Inhibitors Radiation Therapy Guideline
指南简介 原文链接
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

 2020年发布于 Obstetrical & Gynecological Survey 38卷第30期 所属人体系统：生殖 | 卵巢肿瘤

 American Society of Clinical Oncology

Ovarian Cancer Management PARP Inhibitors Guideline
指南简介 原文链接
Olaparib for Maintenance Treatment of Relapsed Platinum-sensitive Ovarian, Fallopian Tube Or Peritoneal Cancer

 2020年发布于 National Institute for Health and Care Excellence 所属人体系统：生殖 | 卵巢肿瘤

 National Institute for Health and Care Excellence

指南简介 原文链接
Ovarian Cancer(Guideline for Patients)

 2021年发布于 National Comprehensive Cancer Network 所属人体系统：生殖 | 卵巢肿瘤

 National Comprehensive Cancer Network

Patient Epithelial Ovarian Cancer treatment stage
指南简介 原文链接
晚期上皮性卵巢癌新辅助化疗指征的快速指南（2021年版）

 2021年发布于中国实用妇科与产科杂志 37卷第4期 所属人体系统：生殖 | 卵巢肿瘤

 中国医师协会微无创医学专业委员会妇科肿瘤学组中国研究型医院学会妇产科专业委员会

上皮性卵巢癌新辅助化疗指征快速指南
指南简介 原文链接
British Gynaecological Cancer Society/British Association of Gynaecological Pathology Consensus for Germline and Tumor Testing for BRCA 1/2 Variants in Ovarian Cancer in the United Kingdom

 2021年发布于 International Journal of Gynecological Cancer 31卷第2期 所属人体系统：生殖 | 卵巢肿瘤

 British Gynaecological Cancer Society/British Association of Gynaecological Pathology

BRCA1 Protein BRCA2 Protein Fallopian Tube Neoplasms Ovarian Neoplasms
指南简介 原文链接
SEOM Clinical Guideline in Ovarian Cancer (2020)

 2021年发布于 Clinical and Translational Oncology 23卷第5期 所属人体系统：生殖 | 卵巢肿瘤

 Spanish Society of Medical Oncology

Diagnosis Guideline Ovarian Cancer Treatment
指南简介 原文链接
Borderline Ovarian Tumors: French Guidelines from the CNGOF. Part 1. Epidemiology, Biopathology, Imaging and Biomarkers

 2021年发布于 Journal of Gynecology Obstetrics and Human Reproduction 50卷第1期 所属人体系统：生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

Borderline Ovarian Tumor Guidelines
指南简介 原文链接
Borderline Ovarian Tumors: French Guidelines from the CNGOF. Part 2. Surgical Management, Follow-up, Hormone Replacement Therapy, Fertility Management and Preservation.

 2021年发布于 Journal of Gynecology Obstetrics and Human Reproduction 50卷第1期 所属人体系统：生殖 | 卵巢肿瘤

 French National College of Obstetricians and Gynecologists

Borderline Ovarian Tumor Guidelines
指南简介 原文链接
Management of Ovarian Cancer: Guidelines of the Italian Medical Oncology Association (AIOM)

 2021年发布于 Tumori 107卷第2期 所属人体系统：生殖 | 卵巢肿瘤

 Italian Medical Oncology Association

Epidemiology and Prevention Guidelines Gynecologic Oncology Molecular Oncology Ovarian Cancer
指南简介 原文链接
Use of Bevacizumab in Advanced Ovarian Cancer: Consensus from an Expert Panel Oncologists

 2021年发布于 Indian Journal of Gynecologic Oncology 所属人体系统：生殖 | 卵巢肿瘤

 无

Advanced Ovarian Cancer Bevacizumab Consensus India Platinum-resistant Ovarian Cancer Platinum-sensitive Ovarian Cancer
指南简介 原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

 2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 卵巢肿瘤

 Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

 2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

 Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Niraparib for Maintenance Treatment of Advanced Ovarian, Fallopian Tube and Peritoneal Cancer after Response to First-line Platinum-based Chemotherapy

 2021年发布于 National Institute for Health and Care Excellence 所属人体系统：生殖 | 卵巢肿瘤

 National Institute for Health and Care Excellence

指南简介 原文链接
Olaparib plus Bevacizumab for Maintenance Treatment of Advanced Ovarian, Fallopian Tube Or Primary Peritoneal Cancer

 2021年发布于 National Institute for Health and Care Excellence 所属人体系统：生殖 | 卵巢肿瘤

 National Institute for Health and Care Excellence

指南简介 原文链接

人体系统

 2020年 发布于 Gynecologie Obstetrique Fertilite et Senologie 48卷 第9期 所属人体系统： 生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

 2020年 发布于 Gynecol Obstet Fertil Senol 48卷 第3期 所属人体系统： 生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

 2020年 发布于 Gynecol Obstet Fertil Senol 48卷 第3期 所属人体系统： 生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

 2020年 发布于 Radiology 294卷 第1期 所属人体系统： 生殖 | 卵巢肿瘤

 American College of Radiology Ovarian-Adnexal Reporting and Data System Committee

 2020年 发布于 Gynecol Obstet Fertil Senol 48卷 第3期 所属人体系统： 生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

 2020年 发布于 Geburtshilfe Und Frauenheilkunde 80卷 第8期 所属人体系统： 生殖 | 卵巢肿瘤

 无

 2020年 发布于 Obstetrical & Gynecological Survey 38卷 第30期 所属人体系统： 生殖 | 卵巢肿瘤

 American Society of Clinical Oncology

 2020年 发布于 National Institute for Health and Care Excellence 所属人体系统： 生殖 | 卵巢肿瘤

 National Institute for Health and Care Excellence

 2021年 发布于 National Comprehensive Cancer Network 所属人体系统： 生殖 | 卵巢肿瘤

 National Comprehensive Cancer Network

 2021年 发布于 中国实用妇科与产科杂志 37卷 第4期 所属人体系统： 生殖 | 卵巢肿瘤

 中国医师协会微无创医学专业委员会妇科肿瘤学组 中国研究型医院学会妇产科专业委员会

 2021年 发布于 International Journal of Gynecological Cancer 31卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

 British Gynaecological Cancer Society/British Association of Gynaecological Pathology

 2021年 发布于 Clinical and Translational Oncology 23卷 第5期 所属人体系统： 生殖 | 卵巢肿瘤

 Spanish Society of Medical Oncology

 2021年 发布于 Journal of Gynecology Obstetrics and Human Reproduction 50卷 第1期 所属人体系统： 生殖 | 卵巢肿瘤

 Collège National Des Gynécologues Et Obstétriciens Français

 2021年 发布于 Journal of Gynecology Obstetrics and Human Reproduction 50卷 第1期 所属人体系统： 生殖 | 卵巢肿瘤

 French National College of Obstetricians and Gynecologists

 2021年 发布于 Tumori 107卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

 Italian Medical Oncology Association

 2021年 发布于 Indian Journal of Gynecologic Oncology 所属人体系统： 生殖 | 卵巢肿瘤

 无

 2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

 Japan Society of Gynecologic Oncology

 2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

 Ontario Health (Cancer Care Ontario)

 2021年 发布于 National Institute for Health and Care Excellence 所属人体系统： 生殖 | 卵巢肿瘤

 National Institute for Health and Care Excellence

 2021年 发布于 National Institute for Health and Care Excellence 所属人体系统： 生殖 | 卵巢肿瘤

 National Institute for Health and Care Excellence

 2020年发布于 Gynecologie Obstetrique Fertilite et Senologie 48卷第9期 所属人体系统：生殖 | 卵巢肿瘤

 2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

 2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

 2020年发布于 Radiology 294卷第1期 所属人体系统：生殖 | 卵巢肿瘤

 2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

 2020年发布于 Geburtshilfe Und Frauenheilkunde 80卷第8期 所属人体系统：生殖 | 卵巢肿瘤

 2020年发布于 Obstetrical & Gynecological Survey 38卷第30期 所属人体系统：生殖 | 卵巢肿瘤

 2020年发布于 National Institute for Health and Care Excellence 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 National Comprehensive Cancer Network 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于中国实用妇科与产科杂志 37卷第4期 所属人体系统：生殖 | 卵巢肿瘤

 中国医师协会微无创医学专业委员会妇科肿瘤学组中国研究型医院学会妇产科专业委员会

 2021年发布于 International Journal of Gynecological Cancer 31卷第2期 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 Clinical and Translational Oncology 23卷第5期 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 Journal of Gynecology Obstetrics and Human Reproduction 50卷第1期 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 Journal of Gynecology Obstetrics and Human Reproduction 50卷第1期 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 Tumori 107卷第2期 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 Indian Journal of Gynecologic Oncology 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 National Institute for Health and Care Excellence 所属人体系统：生殖 | 卵巢肿瘤

 2021年发布于 National Institute for Health and Care Excellence 所属人体系统：生殖 | 卵巢肿瘤